1. PI3K/Akt/mTOR
  2. PI3K
  3. IHMT-PI3K-455

IHMT-PI3K-455 (Compound 15u) 是一种有效,选择性和具有口服活性的 PI3Kγ/δ 双重抑制剂。IHMT-PI3K-455 对 PI3KγPI3KδIC50 分别为 7.1 nM 和 0.57 nM。IHMT-PI3K-455 抑制了 AKT 磷酸化。IHMT-PI3K-455 通过招募和激活更多 CD8+ 杀伤 T 细胞抑制肿瘤生长。IHMT-PI3K-455 可用于肿瘤研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

IHMT-PI3K-455 Chemical Structure

IHMT-PI3K-455 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

IHMT-PI3K-455 (Compound 15u) is a potent, selective, orally active PI3Kγ/δ dual inhibitor with IC50s of 7.1 nM and 0.57 nM for PI3Kγ and PI3Kδ, respectively. IHMT-PI3K-455 suppresses the AKT phosphorylation. IHMT-PI3K-455 inhibits tumor growth by recruiting and activating more CD8+ killing T cells.IHMT-PI3K-455 is used in cancer research[1].

IC50 & Target

PI3Kα

6.717 μM (IC50)

PI3Kβ

42.04 nM (IC50)

PI3Kγ

7.1 nM (IC50)

PI3Kδ

0.57 nM (IC50)

体外研究
(In Vitro)

IHMT-PI3K-455 (1 μM,2 小时) 抑制了 RAW264.7 和 Raji 细胞中 PI3Kγ/δ 介导的 AKT 磷酸化[1]
IHMT-PI3K-455 (1 μM,72 小时) 改变由 THP-1 和 BMDM 细胞衍生的 M2 巨噬细胞的极化[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Differentiation Assay[1]

Cell Line: Macrophages
Concentration: 0.1, 1 μM
Incubation Time: 72 h
Result: Increased the proinflammatory M1 macrophage phenotype in a dose-dependent manner, with a concomitant dose-dependent decrease of the anti-inflammatory M2 macrophage phenotype.
Repolarized M2 phenotype toward M1 phenotype in THP-1 and BMDM macrophages.

Western Blot Analysis[1]

Cell Line: RAW264.7 cells; Raji cells
Concentration: 0, 0.01, 0.03, 0.1, 0.3, 1 μM
Incubation Time: 2 h
Result: Potently inhibited the PI3Kγ-mediated AKT473 phosphorylation in RAW264.7 cells (human C5a stimulation) with an IC50 value of 0.015 μM.
Potently inhibited the PI3Kδ-mediated AKT473 phosphorylation in Raji cells (anti-IgM stimulation) with an IC50 value of 0.010 μM.
体内研究
(In Vivo)

IHMT-PI3K-455 (40 mg/kg,口服;一天一次,连用 30 天) 抑制了 MC38 肿瘤异种移植模型中的肿瘤生长[1]
IHMT-PI3K-455 (40 mg/kg,口服;一天一次,连用 30 天) 通过招募和激活更多 CD8+ 杀伤 T 细胞抑制肿瘤生长[1]
Pharmacokinetic parameters of IHMT-PI3K-455 in Sprague-Dawley rats[1]

Dose (mg/kg) Administration route Cmax (ng/mL) Tmax (h) AUC0-∞ (h⋅ng/mL) T1/2 (h) CL (L/h/kg) Vz (L/kg) F (%)
1 i.v. 1233 0.03 477 1.59 2.12 4.80
10 p.o. 157 3.42 838 2.71 14.76 56.02 17.6

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: MC38 tumor model[1]
Dosage: 10 mg/kg, 40 mg/kg
Administration: Oral gavage (p.o.); Once daily for 30 days
Result: Significantly inhibited tumor size in a dose-dependent manner.
Increased tumor-infiltrating CD8+T cells.
分子量

517.49

Formula

C26H21F2N7O3

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献

IHMT-PI3K-455 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
IHMT-PI3K-455
目录号:
HY-149493
需求量: